martes, 14 de abril de 2015

Safety Alerts for Human Medical Products > Feraheme (ferumoxytol): Drug Safety Communication – Warnings Strengthened and Prescribing Instructions Changed

Safety Alerts for Human Medical Products > Feraheme (ferumoxytol): Drug Safety Communication – Warnings Strengthened and Prescribing Instructions Changed

National Guideline Clearinghouse (NGC)

U.S. Food and Drug Administration (FDA) Advisory

  • March 31, 2015Feraheme (ferumoxytol): FDA is strengthening an existing warning that serious, potentially fatal allergic reactions can occur with the anemia drug Feraheme (ferumoxytol). FDA changed the prescribing instructions and approved a Boxed Warning regarding these serious risks. Also added is a new Contraindication, a strong recommendation against use of Feraheme in patients who have had an allergic reaction to any intravenous (IV) iron replacement product.

No hay comentarios:

Publicar un comentario